Clinical Trial Update: Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating hyperpolarized C-13 pyruvate as a biomarker in advanced solid tumor malignancies, with prostate cancer as a condition; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Rahul Aggarwal | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-04-22